Sale by Nello Mainolfi (Chief Executive Officer)
30,000 shares · @ $81.18 · $2,435,377
Kymera Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $78.47
+5.6% in 7d after detection
Post-detection moves
1h
—
1d
-0.5%
3d
+2.6%
7d
+5.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS